1. Academic Validation
  2. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)

Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)

  • Science. 1996 Mar 22;271(5256):1731-4. doi: 10.1126/science.271.5256.1731.
L A Pennacchio 1 A E Lehesjoki N E Stone V L Willour K Virtaneva J Miao E D'Amato L Ramirez M Faham M Koskiniemi J A Warrington R Norio A de la Chapelle D R Cox R M Myers
Affiliations

Affiliation

  • 1 Department of Genetics, Stanford University School of Medicine, Standford, CA 94305, USA.
Abstract

Progressive myoclonus epilepsy of the Unverricht-Lundborg type (EPM1) is an autosomal recessive inherited form of epilepsy, previously linked to human chromosome 21q22.3. The gene encoding Cystatin B was shown to be localized to this region, and levels of messenger RNA encoded by this gene were found to be decreased in cells from affected individuals. Two mutations, a 3' splice site mutation and a stop codon mutation, were identified in the gene encoding Cystatin B in EPM1 patients but were not present in unaffected individuals. These results provide evidence that mutations in the gene encoding Cystatin B are responsible for the primary defect in patients with EPM1.

Figures